The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Noradrenaline (Norepinephrine) 1:1000 Concentrate For Solution For Infusion

Pfizer Healthcare IrelandPA0822/219/001

Main Information

Trade NameNoradrenaline (Norepinephrine) 1:1000 Concentrate For Solution For Infusion
Active SubstancesNoradrenaline acid tartrate
Dosage FormConcentrate for solution for infusion
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/219/001

Group Information

ATC CodeC01CA Adrenergic and dopaminergic agents
C01CA03 norepinephrine


License statusAuthorised
Licence Issued10/04/1995
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back